National Injury Bureau Logo

TALCUM POWDER CANCER CLAIMS

Talcum Powder is Potentially at Fault in Thousands of Cases of Ovarian Cancer

Free Claim Review ↓

For SMS campaigns: Text STOP to stop and HELP for help. Msg & Data Rates may apply.

Doctor Consulting Patient

Johnson & Johnson Failed to Notify Users of the Cancer Risk. Juries Have Awarded More Than $4.67 Billion to Victims.

Ovarian Cancer is the leading cause of death from cancer of the female reproductive system. Baby powder, also called talcum powder, is a common household product used by millions of women worldwide. What many people don’t know is that Ovarian Cancer in women can be caused by talc-based products. Today, thousands of people have filed claims against Johnson and Johnson for failing to reveal the potential link between their talcum powder and anincreased risk of ovarian cancer. Johnson & Johnson products have been linked to cancer, including Shower to Shower or Johnson’s Baby Powder. In fact, Johnson and Johnson has already paid hundreds of millions of dollars to women and their families through court cases and settlements.

Copyright © 2022 www.nationalinjurybureau.com - All Rights Reserved.

Terms of Service | Privacy Policy | CCPA Notice | Do Not Sell My Info | Accessible View | Contact Us

PAID ATTORNEY ADVERTISEMENT: This Website is a group advertisement. It is not a lawyer referral service. www.nationalinjurybureau.com is owned and operated by National Injury Bureau and is not a law firm. We connect people to legal service and there is no charge to be connected with an attorney. You are under no obligation to retain any services of those connected through our website. We try our best to keep things fair and balanced to help you make the best choice for you. This information does not constitute legal or medical advice and it should not be relied upon as such. Results are not guaranteed and past performance is not an indication of future success. Always consult with your doctor before modifying your medication or regular medical regimen.